ROCK1 also interferes with insulin signaling to increase blood glucose levels and ROCK1 overactivity is associated with metabolic disease states and related comorbidities including obesity, insulin resistance, and dyslipidemia. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.